ARST2031 - A Randomized Phase 3 Trial of Vinorelbine, Dactinomycin, and Cyclophosphamide (VINO-AC) Plus Maintenance Chemotherapy with Vinorelbine and Oral Cyclophosphamide (VINO-CPO) vs Vincristine, Dactinomycin and Cyclophosphamide (VAC) plus VINO-CPO Maintenance in Patients with High Risk Rhabdomyosarcoma (HR-RMS)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Child to Adult
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of Tim Garrington](https://som.ucdenver.edu/FIMS/Content/faculty/4571/CU-Doctors-4571.jpg)
Tim Garrington
Study ID
Protocol Number: 21-4447
More information available at ClinicalTrials.gov: NCT04994132
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers